Lee, H. (2013). Is Extrapolation of the Safety and Efficacy Data in One Indication to Another Appropriate for Biosimilars? Springer US.
Styl cytowania ChicagoLee, Howard. Is Extrapolation of the Safety and Efficacy Data in One Indication to Another Appropriate for Biosimilars? Springer US, 2013.
Styl cytowania MLALee, Howard. Is Extrapolation of the Safety and Efficacy Data in One Indication to Another Appropriate for Biosimilars? Springer US, 2013.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..